Malignant transformation in mature teratoma of the ovary：a clinicopathologic study of 22 cases
10.13315/j.cnki.cjcep.2015.01.005
- VernacularTitle:卵巢成熟性畸胎瘤恶变22例临床病理分析
- Author:
Xudan YANG
;
Lei WANG
;
Xiaoqing WANG
;
Jing FU
;
Yisha LIU
;
Xiaoxiao ZHANG
;
Zhi LIAO
;
Gang XU
- Publication Type:Journal Article
- Keywords:
ovarian neoplasm;
mature teratoma;
malignant transformation;
clinicopathologic features
- From:
Chinese Journal of Clinical and Experimental Pathology
2015;(1):19-23,28
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To study the clinicopathological characteristics in 22 cases of ovarian mature teratoma with malignant transforma-tion. Methods Clinical and pathologic features were collected and analyzed in 22 out of 1 826 cases of ovarian mature teratoma by retrospective studies, together with immunohistochemical staining. Results In our study, 22 cases (1. 2%) of ovarian mature terato-ma with malignant transformation were identified. The median age was 56. 5 (range, 31~79) years. The main clinical manifestations were pelvic masses, including 13 cases in the left ovary, 8 cases in the right, 1 case was bilateral. Gross cystic teratoma were saw in 19 cases, 3 cases of cystic and solid, the bilateral one was solid in the left which the right was cystic. The teratomas size were 5. 0~30 cm with average 12. 4 cm in diameter. The malignant components’ maximum diameter was about 1. 0~10. 0 cm with average 3. 7 cm. Microscopicically, there were poorly differentiated squamous cell carcinoma in 14 cases, carcinoid carcinoma in 4 cases, adeno-carcinoma in 2 cases, papillary thyroid carcinoma in 2 cases, and the last one was sarcomatoid carcinoma. The FIGO stage distribution was as follows:16 were stage IA, 1 was stage IB, 1 was stage IIA, 4 were stage IIB. Follow up showed 6 cases recurrened, 2 patients died, the rest are survival. Conclusions A low incidence of ovarian mature teratoma in somatic cells with malignant transformation, which are common in postmenopausal women and present with pelvic mass. The main malignant components is squamous cell carcino-ma, patients of stage I have better prognosis. Both clinic and pathology should take more attention to the comprehensive examination and diagnosis of teratoma for prevent misdiagnosis.
